Live Breaking News & Updates on Hematology Oncology Association

Stay updated with breaking news from Hematology oncology association. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Luspatercept Receives Positive EU CHMP Opinion for Treatment of Anemia in Lower-Risk MDS

Luspatercept has been recommended for approval by the EMA for patients with transfusion-dependent anemia and lower-risk myelodysplastic syndromes. ....

United States , Bristol Myers Squibb Reblozyl , Anne Kerber , World Health Organization , European Commission , European Union , Bristol Myers Squibb , Head Of Late Clinical Development , International Prognostic Scoring System , European Medicines Agency , Medicinal Products , Human Use , Late Clinical Development , Cell Therapy , Revised International Prognostic Scoring System , Myers Squibb , Myelodysplastic Syndromes , Della Porta , Myeloproliferative Neoplasms ,

Everyday Heroes: DoveLewis volunteer pet blood donors

Usually, a trip to the emergency animal hospital isn't this fun, but 4-year-old Ragnar is always excited to see DoveLewis certified veterinary technician Kelsey ....

Aaron Capps , Kelsey Reinauer , Human Interest , Health Medical Pharma , Blood Bank , Transfusion Medicine , Blood Donation ,

Centra forming new clinic after ending partnership with Lynchburg Hematology and Oncology Clinic

LYNCHBURG, Va. (WFXR)– The Lynchburg Hematology and Oncology Clinic announced it will be ending its professional services agreement after a decade-long partnership with Centra. In a letter sent to patients, Centra said that cancer patients will continue to have access to oncology services in its new Centra Medical Group Hematology and Oncology Clinic. This means […] ....

Thomas Angelo , Oncology Service , Centra Health , Centra Medical Group Hematology , Lynchburg Hematology , Oncology Clinic , Professional Services Agreement , Cancer Patients , Thomas Angelo ,

Novel treatment for polycythemia vera shows promise in clinical trial

A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a multi-center clinical trial led by the Icahn School of Medicine at Mount Sinai. ....

United States , Ronald Hoffman , Yelena Ginzburg , Mount Sinai Health System , Protagonist Therapeutics Inc , Icahn School Of Medicine At Mount Sinai , Sinai Health , Icahn School , New England Journal , Associate Professor , Medical Oncology , Icahn Mount Sinai , Medical Director , Mount Sinai Hospital , Mount Sinai , Protagonist Therapeutics , Blood Cancer , Bell Production , Clinical Trial , Iron Deficiency , Polycythemia Vera , Red Blood Cells ,

Red Cross holds blood drive at Guiding Light Church to help those with Sickle Cell

Sickle Cell Disease is the most common inherited blood disorder in the country. It effects hundreds of thousands across the countryThe disease mainly effects th ....

United States , Guiding Light Church , Shatina Nwosu , Alabama Red Cross , Sunday February , Cell Disease , African American , Red Cross , American Red Cross Blood Donor App , Health Medical Pharma , Blood Donation , Sickle Cell Nephropathy , Health In Africa , Transfusion Medicine , Red Blood Cell , Transfusion Therapy , Blood Transfusion , Sickle Cell Disease ,